News

Technology News

Molecular Diagnostics to Use PierianDx Workstation

Wednesday, August 26, 2015 5:02:00 AM PDT | VentureDeal
   St. Louis, Missouri  --  Molecular Diagnostics Laboratories (MDL) will utilize PierianDx' new clinical workstation, according to a company statement by PierianDx.

MDL will launch its BRCA 1/2 genomic testing program by standardizing on the PierianDx Clinical Genomicist Workstation 3.0 platform.

The company said it had chosen PierianDx' technology to expedite its entry into BRCA testing as well as its extensive knowledge base of thousands of prior medical interpretations for constitutional disorders and somatic cancer.

As a result of this, MDL will be able to "build a future roadmap of assays for genomic testing" on top of the PierianDx technology.

The platform is a cloud-based software application that provides a turnkey solution to manage data and workflow for variant analysis and classification, medical interpretation and reporting.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1